|
|
|
|
|
|
by glasss
697 days ago
|
|
|
For most commercial companies you'll see pharmacy benefits split similarly: 1% - 2% of people on the health plan will account for ~50% of the pharmacy drug spend. That's regardless of overall health of the rest of the members. It's great there's been a lot of innovations for newer drugs that help more people with rare diseases, but specialty drugs just cost a lot. It takes a long time for generics or biosimilars can make it to market. |
|
|
Especially considering the pharmaceutical companies pay the generic manufacturers to stay out of the market. https://www.theatlantic.com/ideas/archive/2023/06/pharmaceut...